Ubiquitin-specific peptidase 9, X-linked (USP9X) modulates activity of mammalian target of rapamycin (mTOR)

Journal of Biological Chemistry

Volumn 287, Issue 25, 2012, Pages 21164-21175

  Agrawal, Pooja ^a   Chen, Yu Ting ^a   Schilling, Birgit ^a   Gibson, Bradford W ^a   Hughes, Robert E ^a  

^a BUCK INSTITUTE FOR RESEARCH ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PARTNERS; CELLULAR PROCESS; EXTRACELLULAR ENVIRONMENTS; GROWTH FACTOR; INDEPENDENT FUNCTIONS; MAMMALIAN TARGET OF RAPAMYCIN (MTOR); MUSCLE CELL; MUSCLE DIFFERENTIATION; MYOBLASTS; MYOTUBES; NEGATIVE REGULATORS; SIGNALING MECHANISMS; SKELETAL MUSCLE DIFFERENTIATION; SKELETAL MYOBLASTS;

AMINO ACIDS; ENZYMES; MUSCLE;

ANTIBIOTICS;

MAMMALIAN TARGET OF RAPAMYCIN; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 2; REGULATOR PROTEIN; UBIQUITIN SPECIFIC PEPTIDASE 9 X LINKED PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL ASSAY; CELL DIFFERENTIATION; CONTROLLED STUDY; DNA SEQUENCE; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME BINDING; ENZYME LOCALIZATION; ENZYME PURIFICATION; ENZYME REGULATION; IMMUNOPRECIPITATION; IN VIVO STUDY; MOUSE; MUSCLE DEVELOPMENT; MYOBLAST; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; UPREGULATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CARRIER PROTEINS; CELL DIFFERENTIATION; ENDOPEPTIDASES; HEK293 CELLS; HUMANS; MICE; MUSCLE DEVELOPMENT; MUSCLE PROTEINS; MYOBLASTS, SKELETAL; PROTEINS; TOR SERINE-THREONINE KINASES; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; UBIQUITIN THIOLESTERASE;

EID: 84862295485     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M111.328021     Document Type: Article

References (53)

1. Hara, K., Maruki, Y., Long, X., Yoshino, K., Oshiro, N., Hidayat, S., Tokunaga, C., Avruch, J., and Yonezawa, K. (2002) Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Cell 110, 177-189 (Pubitemid 34876546)
2. Sarbassov, D. D., Ali, S. M., Kim, D. H., Guertin, D. A., Latek, R. R., Erdjument-Bromage, H., Tempst, P., and Sabatini, D. M. (2004) Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr. Biol. 14, 1296-1302 (Pubitemid 38991819)
3. Zoncu, R., Efeyan, A., and Sabatini, D. M. (2011) mTOR. From growth signal integration to cancer, diabetes, and ageing. Nat. Rev. Mol. Cell Biol. 12, 21-35
4. Jacinto, E., Loewith, R., Schmidt, A., Lin, S., Rüegg, M. A., Hall, A., and Hall, M. N. (2004) Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin-insensitive. Nat. Cell Biol. 6, 1122-1128 (Pubitemid 39468014)
5. Sarbassov, D. D., Ali, S. M., Sengupta, S., Sheen, J. H., Hsu, P. P., Bagley, A. F., Markhard, A. L., and Sabatini, D. M. (2006) Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol. Cell 22,159-168
6. Sengupta, S., Peterson, T. R., and Sabatini, D. M. (2010) Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress. Mol. Cell 40, 310-322
7. Choo, A. Y., and Blenis, J. (2009) Not all substrates are treated equally. Implications for mTOR, rapamycin resistance, and cancer therapy. Cell Cycle 8, 567-572
8. Mamane, Y., Petroulakis, E., LeBacquer, O., and Sonenberg, N. (2006) mTOR, translation initiation, and cancer. Oncogene 25, 6416-6422
9. Oh, W. J., and Jacinto, E. (2011) mTOR complex 2 signaling and functions. Cell Cycle 10, 2305-2316
10. Glass, D. J. (2010) PI3-kinase regulation of skeletal muscle hypertrophy and atrophy. Curr. Top. Microbiol. Immunol. 346, 267-278
11. Ge, Y., Wu, A. L., Warnes, C., Liu, J., Zhang, C., Kawasome, H., Terada, N., Boppart, M. D., Schoenherr, C. J., and Chen, J. (2009) mTOR regulates skeletal muscle regeneration in vivo through kinase-dependent and kinase-independent mechanisms. Am. J. Physiol. Cell Physiol. 297, C1434-C1444
12. Park, I. H., Erbay, E., Nuzzi, P., and Chen, J. (2005) Skeletal myocyte hypertrophy requires mTOR kinase activity and S6K1. Exp. Cell Res. 309, 211-219 (Pubitemid 41199876)
13. Bentzinger, C. F., Romanino, K., Cloëtta, D., Lin, S., Mascarenhas, J. B., Oliveri, F., Xia, J., Casanova, E., Costa, C. F., Brink, M., Zorzato, F., Hall, M. N., and Rüegg, M. A. (2008) Skeletal muscle-specific ablation of raptor, but not of rictor, causes metabolic changes and results in muscle dystrophy. Cell Metab. 8, 411-424
14. Shu, L., and Houghton, P. J. (2009) The mTORC2 complex regulates terminal differentiation of C2C12 myoblasts. Mol. Cell. Biol. 29, 4691-4700
15. Erbay, E., and Chen, J. (2001) The mammalian target of rapamycin regulates C2C12 myogenesis via a kinase-independent mechanism. J. Biol. Chem. 276, 36079-36082
16. Erbay, E., Park, I. H., Nuzzi, P. D., Schoenherr, C. J., and Chen, J. (2003) IGF-II transcription in skeletal myogenesis is controlled by mTOR and nutrients. J. Cell Biol. 163, 931-936 (Pubitemid 37541870)
17. Pantaleon, M., Kanai-Azuma, M., Mattick, J. S., Kaibuchi, K., Kaye, P. L., and Wood, S. A. (2001) FAM deubiquitylating enzyme is essential for preimplantation mouse embryo development. Mech. Dev. 109, 151-160 (Pubitemid 33112028)
18. Murray, R. Z., Jolly, L. A., and Wood, S. A. (2004) The FAM deubiquitylating enzyme localizes to multiple points of protein trafficking in epithelia, where it associates with E-cadherin and β-catenin. Mol. Biol. Cell 15, 1591-1599 (Pubitemid 38401810)
19. Taya, S., Yamamoto, T., Kano, K., Kawano, Y., Iwamatsu, A., Tsuchiya, T., Tanaka, K., Kanai-Azuma, M., Wood, S. A., Mattick, J. S., and Kaibuchi, K. (1998) The Ras target AF-6 is a substrate of the fam deubiquitinating enzyme. J. Cell Biol. 142, 1053-1062 (Pubitemid 28402059)
20. Taya, S., Yamamoto, T., Kanai-Azuma, M., Wood, S. A., and Kaibuchi, K. (1999) The deubiquitinating enzyme Fam interacts with and stabilizes β-catenin. Genes Cells 4, 757-767 (Pubitemid 30053322)
21. Schwickart, M., Huang, X., Lill, J. R., Liu, J., Ferrando, R., French, D. M., Maecker, H., O'Rourke, K., Bazan, F., Eastham-Anderson, J., Yue, P., Dornan, D., Huang, D. C., and Dixit, V. M. (2010) Deubiquitinase USP9X stabilizes MCL1 and promotes tumor cell survival. Nature 463, 103-107
22. Sato, N., Sanjuan, I. M., Heke, M., Uchida, M., Naef, F., and Brivanlou, A. H. (2003) Molecular signature of human embryonic stem cells and its comparison with the mouse. Dev. Biol. 260, 404-413 (Pubitemid 36960088)
23. Van Hoof, D., Passier, R., Ward-Van Oostwaard, D., Pinkse, M. W., Heck, A. J., Mummery, C. L., and Krijgsveld, J. (2006) A quest for human and mouse embryonic stem cell-specific proteins. Mol. Cell. Proteomics 5, 1261-1273 (Pubitemid 44103397)
24. Jolly, L. A., Taylor, V., and Wood, S. A. (2009) USP9X enhances the polarity and self-renewal of embryonic stem cell-derived neural progenitors. Mol. Biol. Cell 20, 2015-2029
25. Bürckstümmer, T., Bennett, K. L., Preradovic, A., Schütze, G., Hantschel, O., Superti-Furga, G., and Bauch, A. (2006) An efficient tandem affinity purification procedure for interaction proteomics in mammalian cells. Nat. Methods 3, 1013-1019 (Pubitemid 44782701)
26. Shilov, I. V., Seymour, S. L., Patel, A. A., Loboda, A., Tang, W. H., Keating, S. P., Hunter, C. L., Nuwaysir, L. M., and Schaeffer, D. A. (2007) The Paragon algorithm, a next generation search engine that uses sequence temperature values and feature probabilities to identify peptides from tandem mass spectra. Mol. Cell. Proteomics 6, 1638-1655 (Pubitemid 47506173)
27. Link, A. J., Eng, J., Schieltz, D. M., Carmack, E., Mize, G. J., Morris, D. R., Garvik, B. M., and Yates, J. R., 3rd. (1999) Direct analysis of protein complexes using mass spectrometry. Nat. Biotechnol. 17, 676-682 (Pubitemid 29316146)
28. Kim, D. H., Sarbassov, D. D., Ali, S. M., King, J. E., Latek, R. R., Erdjument-Bromage, H., Tempst, P., and Sabatini, D. M. (2002) mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 110, 163-175 (Pubitemid 34876545)
29. Izumi, N., Yamashita, A., Iwamatsu, A., Kurata, R., Nakamura, H., Saari, B., Hirano, H., Anderson, P., and Ohno, S. (2010) AAA+ proteins RUVBL1 and RUVBL2 coordinate PIKK activity and function in nonsense-mediated mRNA decay. Sci. Signal. 3, ra27
30. Kaizuka, T., Hara, T., Oshiro, N., Kikkawa, U., Yonezawa, K., Takehana, K., Iemura, S., Natsume, T., and Mizushima, N. (2010) Tti1 and Tel2 are critical factors in mammalian target of rapamycin complex assembly. J. Biol. Chem. 285, 20109-20116
31. Nathan, J. A., Sengupta, S., Wood, S. A., Admon, A., Markson, G., Sanderson, C., and Lehner, P. J. (2008) The ubiquitin E3 ligase MARCH7 is differentially regulated by the deubiquitylating enzymes USP7 and USP9X. Traffic 9, 1130-1145 (Pubitemid 351916888)
32. Sasaki, A., Masuda, Y., Iwai, K., Ikeda, K., and Watanabe, K. (2002) A RING finger protein Praja1 regulates Dlx5-dependent transcription through its ubiquitin ligase activity for the Dlx/Msx-interacting MAGE/Necdin family protein, Dlxin-1. J. Biol. Chem. 277, 22541-22546 (Pubitemid 34967229)
33. Fischer-Vize, J. A., Rubin, G. M., and Lehmann, R. (1992) The fat facets gene is required for Drosophila eye and embryo development. Development 116, 985-1000 (Pubitemid 23042439)
34. Huang, Y., Baker, R. T., and Fischer-Vize, J. A. (1995) Control of cell fate by a deubiquitinating enzyme encoded by the fat facets gene. Science 270, 1828-1831 (Pubitemid 26007231)
35. DiAntonio, A., Haghighi, A. P., Portman, S. L., Lee, J. D., Amaranto, A. M., and Goodman, C. S. (2001) Ubiquitination-dependent mechanisms regulate synaptic growth and function. Nature 412, 449-452 (Pubitemid 32702710)
36. Castilho, R. M., Squarize, C. H., Chodosh, L. A., Williams, B. O., and Gutkind, J. S. (2009) mTOR mediates Wnt-induced epidermal stem cell exhaustion and aging. Cell Stem Cell 5, 279-289
37. Mouchantaf, R., Azakir, B. A., McPherson, P. S., Millard, S. M., Wood, S. A., and Angers, A. (2006) The ubiquitin ligase itch is auto-ubiquitylated in vivo and in vitro but is protected from degradation by interacting with the deubiquitylating enzyme FAM/USP9X. J. Biol. Chem. 281, 38738-38747 (Pubitemid 46042001)
38. Marx, C., Held, J. M., Gibson, B. W., and Benz, C. C. (2010) ErbB2 trafficking and degradation associated with Lys-48 and Lys-63 polyubiquitination. Cancer Res. 70, 3709-3717
39. Al-Hakim, A. K., Zagorska, A., Chapman, L., Deak, M., Peggie, M., and Alessi, D. R. (2008) Control of AMPK-related kinases by USP9X and atypical Lys-29/Lys-33-linked polyubiquitin chains. Biochem. J. 411, 249-260 (Pubitemid 351580177)
40. Dupont, S., Mamidi, A., Cordenonsi, M., Montagner, M., Zacchigna, L., Adorno, M., Martello, G., Stinchfield, M. J., Soligo, S., Morsut, L., Inui, M., Moro, S., Modena, N., Argenton, F., Newfeld, S. J., and Piccolo, S. (2009) FAM/USP9x, a deubiquitinating enzyme essential for TGFβ signaling, controls Smad4 monoubiquitination. Cell 136, 123-135
41. Harrington, L. S., Findlay, G. M., and Lamb, R. F. (2005) Restraining PI3K. mTOR signaling goes back to the membrane. Trends Biochem. Sci. 30, 35-42 (Pubitemid 40093739)
42. Manning, B. D. (2004) Balancing Akt with S6K. Implications for both metabolic diseases and tumorigenesis. J. Cell Biol. 167, 399-403
43. Corradetti, M. N., and Guan, K. L. (2006) Upstream of the mammalian target of rapamycin. Do all roads pass through mTOR? Oncogene 25, 6347-6360 (Pubitemid 44582281)
44. Dibble, C. C., Asara, J. M., and Manning, B. D. (2009) Characterization of Rictor phosphorylation sites reveals direct regulation of mTOR complex 2 by S6K1. Mol. Cell. Biol. 29, 5657-5670
45. Julien, L. A., Carriere, A., Moreau, J., and Roux, P. P. (2010) mTORC1-activated S6K1 phosphorylates Rictor on threonine 1135 and regulates mTORC2 signaling. Mol. Cell. Biol. 30, 908-921
46. Zhang, J., Wu, X. J., Zhuo, D. X., Liu, T., Li, W. R., Mao, Z. B., and Xin, Z. C. (2010) Effect of tankyrase 1 on autophagy in the corpus cavernosum smooth muscle cells from ageing rats with erectile dysfunction and its potential mechanism. Asian J. Androl 12, 744-752
47. Risson, V., Mazelin, L., Roceri, M., Sanchez, H., Moncollin, V., Corneloup, C., Richard-Bulteau, H., Vignaud, A., Baas, D., Defour, A., Freyssenet, D., Tanti, J. F., Le-Marchand-Brustel, Y., Ferrier, B., Conjard-Duplany, A., Romanino, K., Bauché, S., Hantaï, D., Mueller, M., Kozma, S. C., Thomas, G., Rüegg, M. A., Ferry, A., Pende, M., Bigard, X., Koulmann, N., Schaeffer, L., and Gangloff, Y. G. (2009) Muscle inactivation of mTOR causes metabolic and dystrophin defects leading to severe myopathy. J. Cell Biol. 187, 859-874
48. Xie, X., Zhang, D., Zhao, B., Lu, M. K., You, M., Condorelli, G., Wang, C. Y., and Guan, K. L. (2011) IκB kinase ε and TANK-binding kinase 1 activate AKT by direct phosphorylation. Proc. Natl. Acad. Sci. U.S.A. 108, 6474-6479
49. Sasaki, A., Hinck, L., and Watanabe, K. (2005) RumMAGE-D the members. Structure and function of a new adaptor family of MAGE-D proteins. J. Recept. Signal Transduct. Res. 25, 181-198 (Pubitemid 41429006)
50. Reddy, E. M., Chettiar, S. T., Kaur, N., Shepal, V., and Shiras, A. (2010) Dlxin-1, a MAGE family protein, induces accelerated neurite outgrowth and cell survival by enhanced and early activation of MEK and Akt signaling pathways in PC12 cells. Exp. Cell Res. 316, 2220-2236
51. Wang, X., Gao, X., and Xu, Y. (2011) MAGED1. Molecular insights and clinical implications. Ann. Med. 43, 347-355
52. Kuwajima, T., Taniura, H., Nishimura, I., and Yoshikawa, K. (2004) Necdin interacts with the Msx2 homeodomain protein via MAGE-D1 to promote myogenic differentiation of C2C12 cells. J. Biol. Chem. 279, 40484-40493 (Pubitemid 39287639)
53. Nguyen, P. H., Le, T. V., Kang, H. W., Chae, J., Kim, S. K., Kwon, K. I., Seo, D. B., Lee, S. J., and Oh, W. K. (2010) AMP-activated protein kinase (AMPK) activators from Myristica fragrans (nutmeg) and their anti-obesity effect. Bioorg Med. Chem. Lett. 20, 4128-4131